Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

61 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.58M shares of 22.2M outstanding shares and own 16.17% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (2.01M shares), Frazier Life Sciences Management, L.P. (1.07M shares), Versant Venture Management, LLC (507K shares), Ausdal Financial Partners, Inc. (0 shares), GHP Investment Advisors, Inc. (0 shares), Allworth Financial LP (0 shares), Apexium Financial, LP (0 shares), Parallel Advisors, LLC (0 shares), Marquette Asset Management, LLC (0 shares), and Sound Income Strategies, LLC (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.